NASDAQ: ZNTLRUSSELL2000
Zentalis Pharmaceuticals, Inc.
Healthcare · Biotechnology · Headquartered in San Diego, US
Price
Loading chart…
Overview
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Zentalis Pharmaceuticals, Inc., its business model, key products, and controversies.